Indium (In-111) Oxinate

Indium (111In) Oxine, the active ingredient in Indium (In-111) Oxinate, is a radiopharmaceutical presented as a sterile solution for intravenous use. It is employed to label cells or antibodies for diagnostic imaging of infection, inflammation and certain tumors. GNH USA supplies Indium (In-111) Oxinate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and clinics worldwide.

Indium (In-111) Oxinate is used in nuclear medicine to visualize pathological processes that involve immune cell activity or targeted antibodies. - Infection imaging: enables localization of acute bacterial infections by labeling autologous leukocytes. - Inflammation imaging: helps identify sites of inflammatory disease such as vasculitis or sarcoidosis. - Tumor imaging: used to label monoclonal antibodies for detection of certain malignancies in SPECT studies.

Adverse reactions may occur following intravenous administration of Indium (In-111) Oxinate.

Common Side Effects: - Mild injection site pain or erythema - Transient flushing or warmth sensation - Nausea or mild vomiting - Headache - Low‑grade fever - Mild hypotension

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis - Significant hypotension requiring intervention - Radiation‑induced bone marrow suppression - Acute hemolysis - Severe infection or sepsis unrelated to the procedure - Life‑threatening organ toxicity

Prior to use, clinicians should consider several safety measures. - Pregnancy: administer only if the diagnostic benefit outweighs potential fetal radiation risk. - Breastfeeding: assess risk and consider temporary cessation of nursing. - Renal impairment: monitor renal function as clearance may be altered. - Hematologic status: evaluate baseline blood counts due to possible marrow radiation exposure. - Allergy history: verify no known hypersensitivity to indium compounds. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Indium (In-111) Oxinate may interact with other agents that affect imaging quality or patient safety.

Major Interactions (Avoid): - Concurrent administration of other radiopharmaceuticals: can cause image overlap and inaccurate quantification. - Myelosuppressive chemotherapy: may exacerbate radiation‑induced marrow toxicity.

Moderate Interactions (Monitor Closely): - Antibiotics that alter leukocyte function: may affect labeling efficiency. - Immunosuppressants: could modify biodistribution of labeled cells. - Iodinated contrast agents used in CT: may interfere with SPECT image interpretation. - Anticoagulants: monitor for bleeding at injection site.